## Abstract ## Objectives Research suggests that ecstasy users exhibit psychobiological changes relative to nonusers such as altered sleep patterns and cognitive deficits. In turn, it has been suggested that sleep quality may be a mediator of such cognitive deficits in ecstasy users. The present s
Ecstasy use and self-reported disturbances in sleep
β Scribed by Rowan P. Ogeil; Shantha M. W. Rajaratnam; James G. Phillips; Jennifer R. Redman; Jillian H. Broadbear
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 110 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0885-6222
- DOI
- 10.1002/hup.1233
No coin nor oath required. For personal study only.
β¦ Synopsis
Objective
Ecstasy users report a number of complaints after its use including disturbed sleep. However, little is known regarding which attributes of ecstasy use are associated with sleep disturbances, which domains of sleep are affected or which factors may predict those ecstasy users likely to have poor sleep quality and/or excessive daytime sleepiness.
Methods
This study examined questionnaire responses of social drug users (nβ=β395) to the Pittsburgh Sleep Quality Index and the Epworth Sleepiness Scale.
Results
A significant proportion of ecstasy users (69.5%) had Pittsburgh Sleep Quality Index scores above the threshold used to identify sleep disturbance. Although frequency of ecstasy use did not affect the degree of reported sleep disturbance, participants who used larger amounts of ecstasy had poorer sleep. In addition, participants who perceived harmful consequences arising from their ecstasy use or had experienced remorse following ecstasy use had poorer sleep. Clinically relevant levels of sleep disturbance were still evident after controlling for polydrug use. Risk factors for poor sleep quality were younger age, injury postβecstasy use and having been told to cut down on ecstasy use.
Conclusions
Many ecstasy users report poor sleep quality, which likely contributes to the negative effects reported following ecstasy use. Copyright Β© 2011 John Wiley & Sons, Ltd.
π SIMILAR VOLUMES
## Abstract ## Background: Sleep disturbance may represent a risk factor for the development of dementia in Parkinson's disease. However, prior studies exploring the association between specific sleepβwake disturbances and neuropsychological functions have been limited. ## Methods: In this study
Twenty recreational drug users were asked to describe the psychological and physiological eects they experienced under MDMA (3,4-methylenedioxymethamphetamine). The subjects comprised 11 males and nine females, in the age range 18Β±31 years. Five subjects had taken MDMA once, nine had taken it 2Β±9 ti
## Abstract A 38βyearβold man developed parkinsonism that progressed to Hoehn and Yahr stage 5 within 4 years of onset. Response to ropinirole deteriorated, levodopa was not tolerated, and subthalamic nucleus stimulation has provided only partial relief of symptoms. He reported heavy use of Ecstasy
Benzodiazepines produce memory disturbance after acute administration. It is not clear whether chronic use of benzodiazepines is hazardous to memory processes. Epidemiological data indicate that a large proportion (10-30 per cent) of individuals with sleep dysfunction take hypnotic aids for a year o
## Abstract Sleep disturbances are very common in patients with PD and are associated with a variety of negative outcomes. The evaluation of sleep disturbances in these patients is complex, as sleep may be affected by a host of primary sleep disorders, other primary medical or psychiatric condition